FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services home page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

Diversity Council
(A Subcommittee of the FDA Management Council)

  1. Purpose
  2. Background
  3. Scope
  4. Responsibilities
  5. Structure
  6. Procedures
  7. Approval

1. PURPOSE

This charter describes the duties and responsibilities of the Food and Drug Administration (FDA) Diversity Council, the organization of its membership, and its operating procedures. This charter also explains the structure of the Diversity Council, its reporting relationships to the Management Council, the Commissioner of the FDA, and the Director of the Office of Equal Employment Opportunity and Diversity Management (OEEODM).

2. BACKGROUND

The Diversity Council was designed to serve as a working advisory body to the Commissioner of the FDA, the Management Council, and the Director of OEEODM. Its purpose is to foster effective diversity management practices in the agency, promote workforce diversity initiatives, and integrate the principles of diversity in the FDA, in accordance with the FDA’s Policy on Equal Employment Opportunity and Diversity. The Council is a forum to discuss diversity issues; share ideas and information on diversity matters and events; collaborate on and implement diversity initiatives; and leverage organizational resources. Its mission is to foster an environment of acceptance, inclusion, and cooperation.  

3. SCOPE  

The Diversity Council is a sub-committee of the Management Council and serves as an advisory body to the Commissioner of the FDA, the Management Council, and Director of OEEODM, to support and promote the principles of equity and diversity throughout the FDA.

4. RESPONSIBILITIES  

The following are the responsibilities of the Diversity Council:

5. STRUCTURE

 The Diversity Council is a subcommittee of the Management Council and reports to the Management Council. The Diversity Council operates under the auspices of an elected Chairperson and receives staff support from the OEEODM, as available. The Diversity Council comprises voting and non-voting representatives from across the Agency. Council Membership and its respective responsibilities are as follows:

Chairperson/Vice Chairperson:

  1. A Chairperson and Vice Chairperson shall be elected annually by a simple majority of the Diversity Council members present at the time of election. Elections shall be held at the November Council meeting and the newly elected Chairperson and Vice Chairperson shall take office in January. The Chair and Vice-Chair may serve no more than two consecutive terms in each position.
  2. The Chairperson shall preside at all meetings of the Council and have the authority and responsibility customarily conferred on presiding officers.
  3. The Chairperson shall be responsible for directing the activities of the Council and planning its work agendas. The Chairperson shall prepare and disseminate an agenda for each meeting at least seen days in advance of the meeting.
  4. The Chair shall be responsible for maintaining minutes for each meeting of the Council, and other record keeping duties, as necessary.
  5. The Chairperson may appoint task groups to study, research, or report on issues related to the mission of the Council and to implement Council projects, as voted on by the Council. These assignments shall become part of the minutes of the Diversity Council.
  6. The Chairperson shall submit an annual report of the Council’s activities to the Commissioner and Management Council.
  7. In the absence of the Chair, the Vice-Chairperson will assume responsibility for the operation of the Diversity Council.

Voting Members:

  1. Two appointed representatives (one management employee and one non-management employee) from each FDA Center and the Office of the Commissioner.
  2. Two appointed representatives (one management employee and one non-management employee) representing the headquarters office of the Office of Regulatory Affairs.
  3. Two appointed representatives (one management employee and one non-management employee) representing the field offices of the Office of Regulatory Affairs.
  4. Responsibilities for voting members shall be outlined in a Statement of Roles and Responsibilities for Diversity Council Representatives.

 Non-Voting Members:

  1. One Union Representative
  2. The FDA’s Human Resources Liaison

Three Representatives from OEEODM

Other Officers and participants may be appointed/invited to the Council at the discretion of the Chairperson.

6. PROCEDURES

Diversity Council Meetings

  1. The Diversity Council will meet on the first Wednesday of every month in the Parklawn Building utilizing telephonic conference or PicTel communications, as necessary.
  2. The Chairperson shall appoint a person to record meetings, prepare minutes, and distribute materials for review by Council members prior to each meeting. OEEODM shall provide staff support to the Council to the extent that its resources permit.

Method of Conducting Internal Business

  1. The Diversity Council shall take action by the adoption of resolutions. Resolutions shall be adopted by a simple majority vote of the members present at any given Council meeting.
  2. When resolutions are deemed unnecessary, the Council may take action by polling its members for consensus of opinions.
  3. Consensus is reached when, after discussion and without a vote, the majority of the members present agree that an action should or should not be taken.
  4. The Chairperson may appoint committees or working groups at his or her discretion. Such work groups may be long-term/standing or short-term/task oriented. Committees and short-term working groups will be dissolved when their work has been completed.
  5. Amendments – This Charter may be altered, amended, or repealed and a new Charter adopted only upon action by a majority vote of all members present during a regular monthly meeting and with the approval of the Management Council.

7. APPROVAL

Upon signature, this charter will be valid until five years after the effective date at which time, the charter will be certified as current or revised, as needed.

 

horizontal rule

Lester M Crawford, D.V.M., Ph.D.
Acting Commissioner, Food and Drugs

Date

horizontal rule